• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Lymphocyte-sparing radiotherapy

Research Project

Project/Area Number 17K16458
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Radiation science
Research InstitutionKumamoto University

Principal Investigator

Saito Tetsuo  熊本大学, 医学部附属病院, 講師 (30467980)

Project Period (FY) 2017-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Keywordsリンパ球減少 / 放射線治療 / 腫瘍免疫 / リンパ球温存
Outline of Final Research Achievements

We retrospectively assessed patients who had received palliative radiotherapy. The absolute volume of bone marrow that had received 5, 10, 20, and 30 Gy was recorded. Overall, hematologic toxicity (white blood cell, absolute neutrophil count, and platelet) was relatively mild. No bone marrow dose-volume parameter was a significant predictor of hematologic toxicity of grade 2 or higher. Many patients experienced lymphopenia of grade 3 or higher. These findings indicate the high sensitivity of lymphocyte to irradiation.
Patients with esophageal cancer who had received definitive chemoradiotherapy at our Institution were retrospectively assessed. Spleen dose-volume parameters (V5, V10, V20, V30, and mean splenic dose) were significant independent factors negatively influencing the absolute lymphocyte count at nadir. Higher spleen dose-volume parameters were associated with severe lymphopenia during radiotherapy.

Academic Significance and Societal Importance of the Research Achievements

腫瘍免疫において重要な役割を担うT・Bリンパ球に対して、放射線治療は相反する二つの作用を持つ。リンパ球の腫瘍への攻撃に促進的に作用する一方、リンパ球数を減少させることで抑制的にも作用する。本研究では、放射線治療によるリンパ球数減少を軽減することにより、放射線治療の腫瘍免疫への促進的な効果を十分に享受する治療法の確立を目指す。過去の我々の研究結果と合わせ、放射線治療後にリンパ球減少のリスクの高いのは、①照射される体の容積が大きく、②照射回数が多く、③脾臓の多くに高線量照射される場合と考えられる。リンパ球を温存する放射線治療を開発する上ではこれらの要素を考慮に入れる必要がある。

Report

(3 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • Research Products

    (4 results)

All 2018

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 3 results) Presentation (1 results)

  • [Journal Article] Predictors of acute hematologic toxicity attributable to palliative radiotherapy: Analysis of patient characteristics and bone marrow dose-volume parameters2018

    • Author(s)
      Tetsuo Saito, Ryo Toya, Tomohiko Matsuyama, Satoshi Ninomura, Natsuo Oya
    • Journal Title

      JBUON

      Volume: 23 Pages: 261-267

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer2018

    • Author(s)
      Tetsuo Saito, Ryo Toya, Naoya Yoshida, Takashi Shono, Tomohiko Matsuyama, Satoshi Ninomura, Takahiro Watakabe, Yutaka Sasaki, Hideo Baba, Natsuo Oya
    • Journal Title

      In Vivo

      Volume: 32 Issue: 6 Pages: 1519-1525

    • DOI

      10.21873/invivo.11409

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Predictors of acute hematologic toxicity attributable to pal- liative radiotherapy: Analysis of patient characteristics and bone marrow dose-volume parameters2018

    • Author(s)
      Tetsuo Saito, Ryo Toya, Tomohiko Matsuyama, Satoshi Ninomura, Natsuo Oya
    • Journal Title

      JBUON

      Volume: 23 Pages: 261-267

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 食道癌への化学放射線療法に伴うリンパ球数減少を予測するDVHパラメーター2018

    • Author(s)
      斉藤哲雄 東家亮 松山知彦 ニノ村聖 大津家裕仁 大屋夏生
    • Organizer
      第186回日本医学放射線学会九州地方会
    • Related Report
      2018 Annual Research Report 2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi